UB Paderborn / Katalog / Suche / in CDI

1 – 13 von 13

Sortiert nach

Macitentan in pulmonary hypertension due to left ventricular dysfunction

The European respiratory journal, 2018-02, Vol.51 (2), p.1701886-1701886

2018

Link zum Volltext

Verfügbarkeit prüfen

Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension

The European respiratory journal, 2012-10, Vol.40 (4), p.874-880

2012

Link zum Volltext

Verfügbarkeit prüfen

FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion

International journal of cardiology, 2016-01, Vol.202, p.52-58

2016

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion” [Int. J. Cardiol. 202 (2016) 52–58]

International journal of cardiology, 2016-11, Vol.223, p.1072-1073

2016

Link zum Volltext

Verfügbarkeit prüfen

O09 Long-term safety of ustekinumab in paediatric patients with moderate-to-severe plaque psoriasis: results from an ongoing observational study

British journal of dermatology (1951), 2023-08, Vol.189 (3), p.e43-e43

2023

Link zum Volltext

Verfügbarkeit prüfen

Baseline characteristics of patients with PSMA-PET–positive and –negative disease with high-risk of biochemical recurrence (BCR) after radical prostatectomy (RP) in the ongoing phase 3 PRIMORDIUM study

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.119-119

2024

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Macitentan in Patients With Eisenmenger Syndrome: Results From the Randomized, Controlled MAESTRO Study

Circulation (New York, N.Y.), 2019-01, Vol.139 (1), p.51-63

2019

Link zum Volltext

Verfügbarkeit prüfen

MELODY-1: A PILOT STUDY OF MACITENTAN IN PULMONARY HYPERTENSION DUE TO LEFT VENTRICULAR DYSFUNCTION

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.1880-1880

2017

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Macitentan in Patients With Eisenmenger Syndrome

Circulation (New York, N.Y.), 2019-01, Vol.139 (1), p.51-63

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia

Blood, 2013-09, Vol.122 (13), p.2262-2270

2013

Link zum Volltext

Verfügbarkeit prüfen

Physical activity and health-related quality of life in multiple myeloma survivors: the PROFILES registry

BMJ supportive & palliative care, 2020-12, Vol.10 (4), p.e35

2020

Link zum Volltext

Verfügbarkeit prüfen

Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients

Philosophy, ethics, and humanities in medicine : PEHM, 2014-08, Vol.9 (1), p.13-13

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 13 von 13

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(13)

Sprache

Englisch
(13)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Female
(6)
Humans
(6)
Male
(6)
Adult
(5)
Middle Aged
(4)
Aged
(3)
Cardiovascular
(3)
Pulmonary Arterial Hypertension
(3)
Treatment Outcome
(3)
Young Adult
(3)
Administration, Oral
(2)
Adolescent
(2)
Cardiac & Cardiovascular Systems
(2)
Cardiology And Cardiovascular Medicine
(2)
Cardiovascular System & Cardiology
(2)
Data Collection
(2)
Hematology
(2)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Macitentan in pulmonary hypertension due to left ventricular dysfunction

Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension

FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion

Corrigendum to “FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion” [Int. J. Cardiol. 202 (2016) 52–58]

O09 Long-term safety of ustekinumab in paediatric patients with moderate-to-severe plaque psoriasis: results from an ongoing observational study

Baseline characteristics of patients with PSMA-PET–positive and –negative disease with high-risk of biochemical recurrence (BCR) after radical prostatectomy (RP) in the ongoing phase 3 PRIMORDIUM study

Evaluation of Macitentan in Patients With Eisenmenger Syndrome: Results From the Randomized, Controlled MAESTRO Study

A Phase IIIb, Multicentre, Interventional, Randomised, Placebo-Controlled Clinical Trial Investigating the Efficacy and Safety of Guselkumab for the Treatment of Nonpustular Palmoplantar Psoriasis (G-PLUS)

MELODY-1: A PILOT STUDY OF MACITENTAN IN PULMONARY HYPERTENSION DUE TO LEFT VENTRICULAR DYSFUNCTION

Evaluation of Macitentan in Patients With Eisenmenger Syndrome

Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia

Physical activity and health-related quality of life in multiple myeloma survivors: the PROFILES registry

Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients

Suchergebnisse filtern